Syneron Medical Ltd. is proud to announce it has received United States Food and Drug Administration (FDA) clearance for elōs Plus™, a next generation multi-platform system featuring the Company’s proprietary elōs technology. The FDA clearance for elōs Plus follows on the recent international launch in Europe and Asia.
